Surgical Management of Giant Prolactinomas: A Descriptive Study
Introduction. Giant prolactinoma (GP) is a rare pituitary lactotropic cell tumor larger than 4 cm in its widest dimension, and is less likely than a smaller prolactinoma to achieve prolactin normalization on dopamine agonist (DA) monotherapy.
Michelle D. Lundholm +5 more
doaj +4 more sources
Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report [PDF]
Background Dopamine agonists are the standard first-line medical therapy for prolactinoma. We report a rare case of giant prolactinoma with a first epileptic seizure due to rapid reduction of the tumor as a complication of dopamine agonist therapy.
Motofumi Koguchi +6 more
doaj +2 more sources
Giant Prolactinoma of Young Onset: A Clue to Diagnosis of MEN-1 Syndrome [PDF]
Multiple endocrine neoplasia (MEN) type 1 syndrome is an autosomal dominant disorder caused by germline mutations in MEN1 gene, characterized by tumours in endocrine and nonendocrine organs.
Chandrika Jayakanthi Subasinghe +4 more
doaj +2 more sources
Giant prolactinoma, germline BRCA1 mutation, and depression: a case report [PDF]
Background Giant prolactinomas are very rare pituitary tumors that may exhibit an aggressive behavior and present with a life-threatening condition. Case presentation A 25-year-old white woman was admitted to our hospital with a headache, psychomotor ...
Rita Bettencourt-Silva +3 more
doaj +2 more sources
Pituitary apoplexy of a giant prolactinoma during pregnancy
Prolactinomas are a common cause of sexual dysfunction and infertility. We aimed, through this case report, to illustrate the difficulties of management of women with giant prolactinoma, especially in cases of desire of pregnancy.A 30-year-old woman was referred to our department for secondary amenorrhea. Investigations showed a prolactin level of 5168
Taïeb Ach, Maha Kacem, Koussay Ach
exaly +3 more sources
Identification of a novel somatic mutation of POU6F2 by whole‐genome sequencing in prolactinoma
Background Pituitary adenomas (PAs) are one of the most common intracranial tumors; approximately half of PAs are prolactin (PRL)‐secreting PAs (prolactinomas). The genetic alterations prevalent in prolactinomas are unknown.
Yazhou Miao +6 more
doaj +2 more sources
Multimodal management of giant prolactinoma with extensive amyloid spherule deposition: a case report with review of the literature [PDF]
Amyloid spherule-containing prolactinomas are rare entities associated with dopamine agonist (DA) resistance and aggressive behaviour. We report a giant amyloid spherule-containing prolactinoma with a substantial tumour burden and markedly elevated ...
Aysel Unver Ozkahraman +9 more
doaj +2 more sources
A case of giant prolactinoma, initially misdiagnosed as sinonasal neuroendocrine carcinoma
Giant prolactinomas are defined as pituitary tumors greater than 4 cm, often associated with very high prolactin level (>1000 ng/mL). They are relatively rare tumors and can present differently from typical prolactinomas.
Kashif Munir
exaly +3 more sources
Introduction Pituitary tumors from lactotrope cells account for about 40% of all functioning pituitary cancers. Men tend to present with a larger, more invasive and rapid growth prolactinomas than women, possibly because hypogonadism features are less ...
Naji Aljohani
exaly +4 more sources
Giant Prolactinoma in Men: Clinical Features and Therapeutic Outcomes [PDF]
AbstractThe aim of the study was to evaluate the clinical features and long-term therapeutic outcome of giant prolactinoma (gPRLoma) in men and to compare them with those of a group of male patients with non-gPRL macroprolactinomas (non-gPRLomas). A retrospective and multicenter study of gPRLomas in men diagnosed in a 20-year period was performed ...
Juan J Diez +2 more
exaly +3 more sources

